Clinical trials
Enrolling by invitation Cardiomyopathy, Hypertrophic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| American Heart Association | 1 |
| Central State Medical Academy | 1 |
| Cytokinetics | 1 |
| Göteborg University | 1 |
| Johns Hopkins University | 1 |
| Minjie Lu | 1 |
| Petrovsky National Research Centre of Surgery | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| University of British Columbia | 1 |
| Zhejiang Provincial People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 10 |
| Arrhythmogenic Right Ventricular Dysplasia | 3 |
| Cardiomyopathy, Dilated | 2 |
| Death, Sudden, Cardiac | 2 |
| Long QT Syndrome | 2 |
| Polymorphic Catecholaminergic Ventricular Tachycardia | 2 |
| Amyloidosis | 1 |
| Apical Hypertrophic Cardiomyopathy | 1 |
| Brugada Syndrome | 1 |
| Cardiomyopathy, Restrictive | 1 |
Trials
Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.